Metallus Inc. posted a 10% increase in net sales to $308.3 million and a net income of $5.4 million in Q1 2026, driven by higher shipments and improved manufacturing efficiency. Adjusted EBITDA rose 39% to $24.6 million, reflecting stronger demand across all end markets and operational improvements like higher melt utilization. The company invested $24.7 million in capital expenditures, including government-funded projects, and repurchased $4.3 million in shares. Looking ahead, Metallus expects continued profitability growth in 2026, supported by a strong order book, favorable product mix, and pricing improvements.
BioLineRx, a clinical-stage biopharmaceutical company, will release its Q1 2026 financial results on May 27, 2026. Analysts expect an earnings loss of $1.04 per share and revenue of $343,000, reflecting ongoing development costs typical for its growt...
Google Cloud Security used the Instruqt platform to train over 150 professionals on Agentic AI during the Google Next 2026 conference. Each participant worked in a dedicated Google Cloud Vertex AI environment to build and explore AI agents hands-on, ...
At Google Next 2026, Google Cloud Security used the Instruqt platform to train over 150 practitioners on Agentic AI. Each participant received a dedicated Vertex AI environment to build their own AI agents hands-on, moving beyond slide-based demos. T...
At the 2026 Google Next conference, Google Cloud Security used the Instruqt platform to provide hands-on Agentic AI training to over 150 practitioners. Each participant received a dedicated Google Cloud Vertex AI environment to build and explore AI a...
At Google Next 2026, Google Cloud Security used the Instruqt platform to train over 150 professionals in agentic AI capabilities. Each participant received a dedicated Google Cloud Vertex AI environment to build and explore AI agents hands-on, moving...
